Unichem Labs gets USFDA EIR for Roha API facility
Advertisement
Mumbai: Unichem Laboratories Limited has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (APIs) facility at Roha.
The United States Food and Drug Administration (USFDA) conducted the inspection of the Company's Roha facility from 17th to 21st February 2020.
Unichem Labs is one of India's oldest pharmaceutical company headquartered in Mumbai, India.
The Company was founded by Late Mr Amrut V Mody in 1944.
Unichem manufactures and markets a large basket of pharmaceutical formulations across the globe including the regulated markets of the USA and Europe.
Read also: Alembic Pharma gets USFDA Final nod for Doxycycline Hyclate Tablets
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.